Notizia - Recent Pharma, Healthcare and Biotech Happenings

FDA permits COVID-19 treatments with blood from survivors The FDA revealed the convalescent plasma use that is derived from the donated blood of people that have recovered from COVID-19 and that might have beneficial antibodies. It is being used as an investigational treatment for patients with severe cases of the disease. The method has been used for years for treating infectious diseases, to transmit newly acquired immunity from one person to another. Lately, it has been investigated in the H1N1 swine flu, Ebola, SARS and MERS epidemics and against the novel coronavirus in China too, though it is now unknown how well it will perform. The FDA apprised that a...